Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses

NCT00570843 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

NETWORK

Sponsor class

Conditions

Comfort, Vision and Wear Time

Interventions

DRUG: New PEG based artificial tear
DRUG: Optive

Sponsor

Bp Consulting, Inc